US SEC Trading Suspension Halt Orders — September 29, 2026

USA Trading Suspensions

By Gunpowder Editorial ·

4 high priority 4 total filings analysed

Executive Summary

The four filings in this digest highlight a significant wave of regulatory and structural stress across US-listed companies, with three of four facing Nasdaq delisting risks and one completing a going-private transaction. Notably, all three Nasdaq-related filings involve compliance failures (delinquent filings, bid price deficiencies), suggesting a pattern of small-cap distress.

SurgePays and Liminatus Pharma have received extensions or regained compliance, but both face ongoing financial challenges, with SurgePays' future hinging on a potential reverse split. Maison Solutions' delinquency is the most severe, with a tight timeline to submit a compliance plan. In contrast, Global Business Travel Group's $6.3 billion acquisition by Long Lake Management represents a successful exit, with stockholders receiving a 65.1% premium. The overall sentiment is predominantly negative, with only the GBT deal offering a positive outcome, reflecting a bifurcated market where distressed small caps struggle while larger entities find strategic exits.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: 8-K

Tracking the trend? Catch up on the prior US SEC Trading Suspension Halt Orders digest from September 28, 2026.

Investment Signals (8)

  • Acquisition completed at $9.50/share, a 65.1% premium to 30-day VWAP, providing immediate cash exit for stockholders

  • Regained compliance with bid price rule after 1-for-50 reverse split, removing immediate delisting threat

  • SurgePays ↓ (BULLISH)
    ▲

    Granted 180-day extension to March 22, 2027, to regain bid price compliance, providing time to execute a cure

  • Received delinquency notice for 10-Q and 10-K; stock continues to trade, but compliance plan deadline is October 19, 2026

  • SurgePays ↓ (NEUTRAL)
    ▲

    Confirmed meeting stockholders' equity requirement, resolving a prior deficiency, but future compliance is not assured

  • Compliance achieved only after a 1-for-50 reverse split, indicating severe share price weakness and potential for further dilution

  • Acquisition financed with equity from Long Lake investors and committed debt, indicating strong sponsor backing

  • As an emerging growth company, it may have flexibility in compliance, but the delinquency signals potential operational or reporting issues

Risk Flags (7)

Opportunities (6)

Sector Themes (5)

  • Small-Cap Distress
    ◆

    3 of 4 filings involve Nasdaq compliance issues, indicating a broader trend of small-cap companies struggling with listing requirements

  • Reverse Split Reliance
    ◆

    Two companies (SurgePays, Liminatus) are using or considering reverse splits to maintain listing, a common but often value-destructive tactic

  • Regulatory Scrutiny
    ◆

    Increased frequency of delinquency notices suggests tighter enforcement by Nasdaq, impacting investor confidence in small caps

  • Private Equity Exits
    ◆

    GBT's acquisition highlights a trend of PE firms taking public companies private at premiums, offering liquidity in a challenging IPO market

  • Financial Health Divergence
    ◆

    While GBT completed a premium acquisition, the other three companies face financial distress, illustrating a bifurcation between healthy and struggling companies

Watch List (6)

  • Compliance plan submission deadline October 19, 2026; monitor for acceptance and subsequent filing progress

  • Reverse split announcement potential; monitor bid price trends and any operational updates before March 22, 2027

  • Monitor for operational updates and any signs of continued financial stress post-compliance

  • Watch for any post-acquisition announcements regarding AI integration and private operations

  • Nasdaq Compliance Trends
    👁

    Monitor for other small-cap companies receiving similar delinquency notices, indicating sector-wide stress

  • Regulatory Environment
    👁

    Watch for any changes in Nasdaq listing rules that could impact compliance timelines

Filing Analyses (4)
Maison Solutions Inc. 8-K negative materiality 8/10

29-09-2026

Maison Solutions Inc. received a Nasdaq notification on September 23, 2026, for failure to comply with Listing Rule 5250(c)(1) due to delinquent filing of its Form 10-Q for the quarter ended July 31, 2026, and its Form 10-K for the fiscal year ended April 30, 2026. The company has until October 19, 2026, to submit a compliance plan; if accepted, it may have until February 9, 2027, to file the reports. The stock continues to trade on Nasdaq under 'MSS' with no immediate delisting effect, but the company faces potential delisting if it fails to regain compliance.

  • · The company is an emerging growth company and has not elected to use the extended transition period for complying with new or revised financial accounting standards.
  • · The company's grocery retail operations are located in Southern California and Arizona under the HK Good Fortune and Lee Lee International brands.
  • · The company plans to file the Form 10-K and Form 10-Q as promptly as practicable to regain compliance.
SurgePays, Inc. 8-K negative materiality 9/10

29-09-2026

SurgePays, Inc. received Nasdaq notice granting a 180-day extension until March 22, 2027, to regain compliance with the minimum $1.00 bid price per share requirement. Additionally, Nasdaq confirmed the company now meets the minimum stockholders' equity requirement, resolving a prior deficiency, but cautioned that failure to maintain compliance in future filings could lead to delisting. There is no assurance that SurgePays will ultimately regain or sustain compliance with Nasdaq's listing rules.

  • · The initial compliance period for the bid price deficiency expired on September 21, 2026.
  • · Nasdaq's extension grant was conditioned on SurgePays meeting all other initial listing requirements for The Nasdaq Capital Market except the bid price rule, and on the company's written intention to cure via a reverse stock split if needed.
  • · If compliance is not regained by March 22, 2027, Nasdaq will issue a delisting notice, and a hearing request would not suspend trading.
  • · The company still faces the risk of delisting if it fails to evidence compliance with continued listing criteria in its next periodic report.
Global Business Travel Group, Inc. 8-K positive materiality 9/10

29-09-2026

Global Business Travel Group, Inc. (Amex GBT) completed its $6.3 billion all-cash acquisition by Long Lake Management, with stockholders receiving $9.50 per share, a 65.1% premium to the 30-day VWAP. The company has ceased trading on the NYSE and will operate as a private entity, with Long Lake's AI engineering team expected to enhance Amex GBT's travel services. The transaction was financed through equity from Long Lake's investors, including Koch Equity Development, and committed debt financing.

  • · Acquisition was previously announced on May 4, 2026, and approved by stockholders on August 3, 2026.
  • · Long Lake was founded in 2023 and is backed by investors including General Catalyst, Alpha Wave, Elad Gil, D1, and Thrive.
  • · Financing includes equity from Long Lake's existing investors and Koch Equity Development, plus committed debt financing.
  • · Amex GBT operates in more than 140 countries.
  • · Advisors included Rothschild & Co (financial) and Kirkland & Ellis (legal) for the Special Committee; Skadden for Amex GBT; Latham & Watkins for Long Lake; Moelis & Company for Koch Equity Development.
Liminatus Pharma, Inc. 8-K mixed materiality 8/10

29-09-2026

Liminatus Pharma, Inc. (LIMNW) received a Nasdaq notice on September 24, 2026, confirming it has regained compliance with the minimum bid price rule (Bid Price Rule) after its common stock closed above $1.00 per share for 13 consecutive trading days following a 1-for-50 reverse stock split on August 20, 2026. The company had previously been at risk of delisting due to its stock price falling below $1.00 for 30 consecutive business days, but a Nasdaq Hearings Panel granted an extension and transferred the listing to the Nasdaq Capital Market. The compliance resolution removes the immediate delisting threat, though the reverse split and prior non-compliance highlight ongoing financial challenges.

  • · The company was transferred from The Nasdaq Global Market to The Nasdaq Capital Market effective August 4, 2026.
  • · The reverse stock split was effected on August 20, 2026.
  • · The compliance period measured was August 21, 2026 to September 9, 2026.
  • · The company is an emerging growth company and has not elected the extended transition period for complying with new financial accounting standards.

Get daily alerts with 8 investment signals, 7 risk alerts, 6 opportunities and full AI analysis of all 4 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: US SEC Trading Suspension Halt Orders

🇺🇸 More from United States

View all →